RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Transforming Cold Tumors into Hot Ones with a Metal-Organic Framework-Based Biomimetic Nanosystem for Enhanced Immunotherapy.
Transforming Cold Tumors into Hot Ones with a Metal-Organic Framework-Based Biomimetic Nanosystem for Enhanced Immunotherapy.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
免疫疗法已经彻底改变了临床肿瘤治疗的格局,尽管由于复杂的肿瘤微环境(TME),"冷"肿瘤的缓解率相对较低。环鸟苷酸-腺苷酸合成酶/干扰素基因刺激因子(cGAS/STING)通路诱导剂可以重编程TME;然而,其应用仍未得到充分利用。
在此,我们构建了一种简便的锰基金属有机框架(Mn-MOF),封装重楼皂苷I(PPI)并用红细胞(RBC)膜包覆(RBC@Mn-MOF/PPI),从而增强cGAS/STING介导的抗肿瘤免疫。RBC@Mn-MOF/PPI通过仿生RBC膜伪装进行工程化设计,以实现延长血液循环和免疫逃逸,同时还赋予其对TME敏感的 properties,触发PPI和Mn 2+的释放以重塑抑制性TME并增强抗肿瘤免疫应答。
此外,RBC@Mn-MOF/PPI通过激活免疫细胞帮助将冷肿瘤转化为"热"肿瘤,树突状细胞成熟、细胞毒性T淋巴细胞浸润和NK 细胞募集均证实了这一点,从而靶向原发性和远隔肿瘤及肺转移结节。
因此,我们工程化的纳米系统代表了一种通过激活cGAS/STING通路将免疫"冷"肿瘤转化为"热"肿瘤的新策略,从而解决免疫疗法相关的主要挑战。
Immunotherapy has revolutionized the landscape in clinical tumor therapy, although the response rates in "cold" tumors are relatively low owing to the complex tumor microenvironment (TME). Cyclic guanosine monophosphate-adenosine monophosphate synthase/stimulator of interferon genes (cGAS/STING) pathway-inducing agents can reprogram the TME; however, their applications remain underutilized.
Herein, we engineered a facile manganese-based metal-organic framework (Mn-MOF) encapsulating polyphyllin I (PPI) and coated it with red blood cell (RBC) membranes (RBC@Mn-MOF/PPI) that enhanced the cGAS/STING-mediated antitumor immunity. RBC@Mn-MOF/PPI was engineered by camouflaging it with a biomimetic RBC membrane for prolonged blood circulation and immune escape, which was also extended with TME-sensitive properties for triggering the release of PPI and Mn 2+ to remodel the suppressive TME and augment antitumor immune responses.
Furthermore, RBC@Mn-MOF/PPI helped transform cold tumors into "hot" ones by activating immune cells, as evidenced via dendritic cell maturation, cytotoxic T lymphocyte infiltration, and natural killer cell recruitment, thereby targeting primary and abscopal tumors and lung metastatic nodules.
Therefore, our engineered nanosystem represents a novel strategy to transform immunologically "cold" tumors into "hot" ones by activating the cGAS/STING pathway, thereby addressing the major challenges associated with immunotherapy.
MEMBER ACCOUNT
登录成功会直接打开下一页。